Dong-Cheol Kim Selected Research

hexamethylenetriperoxidediamine

1/2018

Heme Oxygenase-1-Inducing Activity of 4-Methoxydalbergione and 4'-Hydroxy-4-methoxydalbergione from Dalbergia odorifera and Their Anti-inflammatory and Cytoprotective Effects in Murine Hippocampal and BV2 Microglial Cell Line and Primary Rat Microglial Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong-Cheol Kim Research Topics

Disease

5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2014
4	Neuroinflammatory Diseases 12/2018 - 02/2016
2	Inflammation (Inflammations) 05/2020 - 04/2016
1	Necrosis 01/2021
1	Neoplasms (Cancer) 01/2021
1	Brain Injuries (Brain Injury) 10/2015
1	Melanoma (Melanoma, Malignant) 07/2014
1	Carcinoma (Carcinomatosis) 07/2014

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2021 - 12/2017
2	p38 Mitogen-Activated Protein KinasesIBA 05/2020 - 09/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	nardostachinIBA 01/2021
1	InterleukinsIBA 01/2021
1	NF-kappa B (NF-kB)IBA 05/2020
1	cudraflavanone AIBA 12/2018
1	hexamethylenetriperoxidediamineIBA 01/2018
1	steppogeninIBA 12/2017
1	cudratricusxanthone AIBA 09/2016
1	LipopolysaccharidesIBA 09/2016
1	xanthoneIBA 09/2016
1	TMC 256C1IBA 04/2016
1	Glutamic Acid (Glutamate)FDA Link 04/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016
1	Pharmaceutical PreparationsIBA 02/2016
1	Monoamine Oxidase (MAO)IBA 07/2014
1	cudraflavone BIBA 07/2014
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2014

Therapy/Procedure

1	Therapeutics 10/2015